KOZLOVÁ, Veronika, Aneta LEDEREROVÁ, Viera VAKULOVÁ, Michael DOUBEK, Jiří MAYER, Šárka POSPÍŠILOVÁ a Michal ŠMÍDA. CD20 knockout cell lines obtained using CRISPR/Cas9 have no significant defect in BCR signaling in B-lymphoid malignancies. In CEITEC PHD RETREAT II, Telč. 2017. |
Další formáty:
BibTeX
LaTeX
RIS
@proceedings{1383728, author = {Kozlová, Veronika and Ledererová, Aneta and Vakulová, Viera and Doubek, Michael and Mayer, Jiří and Pospíšilová, Šárka and Šmída, Michal}, booktitle = {CEITEC PHD RETREAT II, Telč}, keywords = {CD20; defect; cell}, language = {eng}, title = {CD20 knockout cell lines obtained using CRISPR/Cas9 have no significant defect in BCR signaling in B-lymphoid malignancies}, year = {2017} }
TY - CONF ID - 1383728 AU - Kozlová, Veronika - Ledererová, Aneta - Vakulová, Viera - Doubek, Michael - Mayer, Jiří - Pospíšilová, Šárka - Šmída, Michal PY - 2017 TI - CD20 knockout cell lines obtained using CRISPR/Cas9 have no significant defect in BCR signaling in B-lymphoid malignancies KW - CD20 KW - defect KW - cell N2 - CD20 knockout cell lines obtained using CRISPR/Cas9 have no significant defect in BCR signaling in B-lymphoid malignancies, CD20 knockout cell lines obtained using CRISPR/Cas9 have no significant defect in BCR signaling in B-lymphoid malignancies ER -
KOZLOVÁ, Veronika, Aneta LEDEREROVÁ, Viera VAKULOVÁ, Michael DOUBEK, Jiří MAYER, Šárka POSPÍŠILOVÁ a Michal ŠMÍDA. CD20 knockout cell lines obtained using CRISPR/Cas9 have no significant defect in BCR signaling in B-lymphoid malignancies. In \textit{CEITEC PHD RETREAT II, Telč}. 2017.
|